Evidence map›Paper›PMID 33806791›Full record

ArticleInternational journal of molecular sciences2021

The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health.

Clarisse Roblin, Steve Chiumento, Cédric Jacqueline, Eric Pinloche, Cendrine Nicoletti, Hamza Olleik, Elise Courvoisier-Dezord, Agnès Amouric, Christian Basset, Louis Dru and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Total Synthesis and Stereochemical Assignment of Enteropeptin A.Journal of the American Chemical Society · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Clarisse RoblinCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.ORCID 0000-0002-4710-1138
Steve ChiumentoUniversity Grenoble Alpes, CEA, IRIG, CBM, CNRS UMR5249, 38054 Grenoble, France.
Cédric JacquelineEA3826, IRS2 Nantes-Biotech, Université de Nantes, 44200 Nantes, France.ORCID 0000-0001-9606-5930
Eric PinlocheCentre d'Expertise et de Recherche en Nutrition, ADISSEO France SAS, 03600 Commentry, France.
Cendrine NicolettiCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.ORCID 0000-0002-0086-6707
Hamza OlleikCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.ORCID 0000-0002-3995-2207
Elise Courvoisier-DezordCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.
Agnès AmouricCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.
Christian BassetUniversity Grenoble Alpes, CEA, IRIG, CBM, CNRS UMR5249, 38054 Grenoble, France.
Louis DruCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.
Marie OllivierBioAzur Biogroup-Vet'Analys Laboratory, 83400 Hyères, France.
Aurélie Bogey-LambertBioAzur Biogroup-Vet'Analys Laboratory, 83400 Hyères, France.
Nicolas VidalYelen Analytics, Aix-Marseille University ICR, 13013 Marseille, France.
Mohamed AttaUniversity Grenoble Alpes, CEA, IRIG, CBM, CNRS UMR5249, 38054 Grenoble, France.
Marc MarescaCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.ORCID 0000-0002-3585-4765
Estelle DevillardCentre d'Expertise et de Recherche en Nutrition, ADISSEO France SAS, 03600 Commentry, France.ORCID 0000-0002-0644-7802
Victor DuarteUniversity Grenoble Alpes, CEA, IRIG, CBM, CNRS UMR5249, 38054 Grenoble, France.
Josette PerrierCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.
Mickael LafondCNRS, Aix-Marseille University, Centrale Marseille, iSm2, 13013 Marseille, France.ORCID 0000-0003-2646-0286
Centre National de la Recherche Scientifique · FRAix-Marseille Université · FRNantes Université · FR

Funding

Agence Nationale de la Recherche ANR-10-INBS-08Agence Nationale de la Recherche ANR-15-CE21-0020Agence Nationale de la Recherche ANR-20-CE44-0021Association Nationale de la Recherche et de la Technologie 2016/0657LABoratoires d'EXcellence ARCANE ANR-17-EURE-0003
6 · The paper itself

Abstract

The world is on the verge of a major antibiotic crisis as the emergence of resistant bacteria is increasing, and very few novel molecules have been discovered since the 1960s. In this context, scientists have been exploring alternatives to conventional antibiotics, such as ribosomally synthesized and post-translationally modified peptides (RiPPs). Interestingly, the highly potent in vitro antibacterial activity and safety of ruminococcin C1, a recently discovered RiPP belonging to the sactipeptide subclass, has been demonstrated. The present results show that ruminococcin C1 is efficient at curing infection and at protecting challenged mice from

Indexed as

Anti-Bacterial AgentsAntifungal AgentsBacteriocinsBiofilmsClostridium InfectionsClostridium perfringensEubacterialesHumansPeptidesProtein Processing, Post-TranslationalAnti-Bacterial AgentsAntifungal AgentsBacteriocinsPeptidesantibioticsantimicrobial resistanceClostridium perfringensmicrobiomeperitonitis infectionRiPPRuminococcus gnavus E1sactipeptide

Identifiers

PMID33806791
PMCPMC8005207
OpenAlexW3139375672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.